OpenBilldrug price receipt

NADAC week of 2026-10-14

LEVALBUTEROL TAR HFA 45 MCG INH

For 1 g

Pharmacies pay

$3.55 filed

1 × $3.54974 per GM

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$3.45 filed

1 × $3.45445 per GM, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.97× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Levalbuterol Tartrate HFA” / “Levalbuterol Tartrate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.08 estimated

$3.55 + $0.53 (15%) + $5.00 fee per fill = $9.08

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LEVALBUTEROL TAR HFA 45 MCG INH is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levalbuterol tartrate, under the trade name “Levalbuterol tartrate HFA inhalation”.

FDA gives its dosage form as aerosol, metered and its route as oral.

The labeler, the company named on the label, is Actavis Pharma, Inc.

FDA’s Established Pharmacologic Class for it is beta2-Adrenergic Agonist.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00591-2927-54.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.55 for 1 g (1 × $3.54974 per GM, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NDC

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name levalbuterol tartrate with LEVALBUTEROL TAR HFA 45 MCG INH.

ProductPharmacies pay per unitMedicare per unit
LEVALBUTEROL TAR HFA 45 MCG INH this page
generic · aerosol, metered
$3.54974 per GM filed
eff. 2026-09-23
$3.45445 per GM filed
Part D 2024 average
XOPENEX HFA 45 MCG INHALER
brand · aerosol, metered
$4.98775 per GM filed
eff. 2026-09-23
$4.57361 per GM filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $3.54974 per GM filed.

Of the 24 other products in FDA’s beta2-Adrenergic Agonist class priced per GM, 22 have a higher middle NADAC price and 2 a lower one. The one in the middle is BREYNA 160-4.5 MCG INHALER, at $21.61843 per GM filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $3.45 for 1 g, at an average of $3.45445 per GM in 2024 (2024-01-01 to 2024-12-31) for “Levalbuterol Tartrate HFA” and “Levalbuterol Tartrate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 251,600 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for LEVALBUTEROL TAR HFA 45 MCG INH labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Levalbuterol Tartrate HFA / Levalbuterol Tartrate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's GM. Joined on generic name.
Why does this page start at 1 g?
The FDA package description of NDC 00591-2927-54 (“1 INHALER in 1 CARTON (0591-2927-54) / 200 AEROSOL, METERED in 1 INHALER”) does not give one amount in g, NADAC’s unit for this product. So the card starts at 1 GM; change it to match your prescription.